Continuing its manufacturing revamp, Pfizer unloads another Tennessee plant

Pfizer ($PFE) sold a former King Pharmaceuticals plant, acquired along with that company in 2011, to UPM Pharmaceuticals as part of an effort to streamline its manufacturing. UPM's top leadership is familiar with the Bristol, TN, facility; CEO John Gregory started King Pharma back in 1994. Report